JP2023531189A5 - - Google Patents
Info
- Publication number
- JP2023531189A5 JP2023531189A5 JP2022577490A JP2022577490A JP2023531189A5 JP 2023531189 A5 JP2023531189 A5 JP 2023531189A5 JP 2022577490 A JP2022577490 A JP 2022577490A JP 2022577490 A JP2022577490 A JP 2022577490A JP 2023531189 A5 JP2023531189 A5 JP 2023531189A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- antibody
- nos
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025247571A JP2026053430A (ja) | 2020-06-18 | 2025-12-12 | 条件的に活性な抗ｃｄ４６抗体、抗体断片、それらの免疫コンジュゲート及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063040913P | 2020-06-18 | 2020-06-18 | |
| US63/040,913 | 2020-06-18 | ||
| PCT/US2021/037400 WO2021257542A1 (en) | 2020-06-18 | 2021-06-15 | Conditionally active anti-cd46 antibodies, antibody fragments, their immunoconjugates and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025247571A Division JP2026053430A (ja) | 2020-06-18 | 2025-12-12 | 条件的に活性な抗ｃｄ４６抗体、抗体断片、それらの免疫コンジュゲート及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023531189A JP2023531189A (ja) | 2023-07-21 |
| JP2023531189A5 true JP2023531189A5 (https=) | 2024-06-18 |
| JP7795206B2 JP7795206B2 (ja) | 2026-01-07 |
Family
ID=79268294
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577490A Active JP7795206B2 (ja) | 2020-06-18 | 2021-06-15 | 条件的に活性な抗ｃｄ４６抗体、抗体断片、それらの免疫コンジュゲート及びその使用 |
| JP2025247571A Pending JP2026053430A (ja) | 2020-06-18 | 2025-12-12 | 条件的に活性な抗ｃｄ４６抗体、抗体断片、それらの免疫コンジュゲート及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025247571A Pending JP2026053430A (ja) | 2020-06-18 | 2025-12-12 | 条件的に活性な抗ｃｄ４６抗体、抗体断片、それらの免疫コンジュゲート及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230242662A1 (https=) |
| EP (1) | EP4168452A4 (https=) |
| JP (2) | JP7795206B2 (https=) |
| KR (1) | KR20230023800A (https=) |
| CN (1) | CN115702167A (https=) |
| AU (1) | AU2021292486A1 (https=) |
| CA (1) | CA3182384A1 (https=) |
| IL (1) | IL298902A (https=) |
| MX (1) | MX2022016197A (https=) |
| TW (1) | TWI906314B (https=) |
| WO (1) | WO2021257542A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0624500D0 (en) * | 2006-12-07 | 2007-01-17 | Istituto Superiore Di Sanito | A novel passive vaccine for candida infections |
| AU2011295715B9 (en) * | 2010-09-03 | 2017-02-23 | Abbvie Stemcentrx Llc | Novel modulators and methods of use |
| JP6730260B2 (ja) * | 2014-09-12 | 2020-07-29 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | マクロピノサイトーシスによるヒト抗ｃｄ４６抗体及び標的とされた癌治療薬 |
| CA2874083C (en) * | 2014-12-05 | 2024-01-02 | Universite Laval | Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases |
| WO2017078839A1 (en) * | 2015-11-02 | 2017-05-11 | Bioatla, Llc | Conditionally active polypeptides |
| AU2017320874B2 (en) * | 2016-08-31 | 2024-03-07 | Bioatla, Llc | Conditionally active polypeptides and methods of generating them |
| CA3043277A1 (en) * | 2016-11-11 | 2018-05-17 | The Regents Of The University Of California | Anti-cd46 antibodies and methods of use |
| CN109535260B (zh) * | 2018-11-22 | 2021-08-10 | 东南大学 | 一种靶向cd46的人源嵌合抗原受体及其应用 |
-
2021
- 2021-06-15 EP EP21824799.7A patent/EP4168452A4/en active Pending
- 2021-06-15 US US18/002,010 patent/US20230242662A1/en active Pending
- 2021-06-15 MX MX2022016197A patent/MX2022016197A/es unknown
- 2021-06-15 KR KR1020237001966A patent/KR20230023800A/ko active Pending
- 2021-06-15 AU AU2021292486A patent/AU2021292486A1/en active Pending
- 2021-06-15 CA CA3182384A patent/CA3182384A1/en active Pending
- 2021-06-15 JP JP2022577490A patent/JP7795206B2/ja active Active
- 2021-06-15 WO PCT/US2021/037400 patent/WO2021257542A1/en not_active Ceased
- 2021-06-15 IL IL298902A patent/IL298902A/en unknown
- 2021-06-15 CN CN202180043149.6A patent/CN115702167A/zh active Pending
- 2021-06-18 TW TW110122286A patent/TWI906314B/zh active
-
2025
- 2025-12-12 JP JP2025247571A patent/JP2026053430A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023531185A5 (https=) | ||
| JP7335290B2 (ja) | 二重特異性四価抗体並びにその製作及び使用方法 | |
| JP6817492B2 (ja) | 高いインビボ忍容性を有するアントラサイクリン系の抗体薬物複合体 | |
| JP2022116283A (ja) | 三重特異性タンパク質と使用方法 | |
| JP7474193B2 (ja) | 多重特異性抗体とその作製及び使用方法 | |
| JP2022101693A5 (https=) | ||
| JP7399852B2 (ja) | 多重特異性抗体とその作製及び使用方法 | |
| JP2020529864A5 (https=) | ||
| JP2022513420A5 (https=) | ||
| JP2020502271A5 (https=) | ||
| JP2011501656A5 (https=) | ||
| US11643437B2 (en) | Tandem repeat cancer-targeting peptides for molecular conjugation or engineering and uses thereof in cancer theranostics | |
| JP2019524640A5 (https=) | ||
| JP2023502876A5 (https=) | ||
| JP2024542192A5 (https=) | ||
| WO2023034566A1 (en) | Anti-dll3 antibodies and uses thereof | |
| US20240124608A1 (en) | Methods and materials for treating clonal t cell expansions | |
| JP2025526112A (ja) | 二特異性結合剤を使用するｅｇｆｒの分解 | |
| Sapski et al. | Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response | |
| JP2023511403A5 (https=) | ||
| JP2023531189A5 (https=) | ||
| JP2023536630A5 (https=) | ||
| CA3165685C (en) | Tandem repeat cancer-targeting peptides for molecular conjugation or engineering and uses thereof in cancer theranostics | |
| JP2026511082A (ja) | 核局在化ポリペプチド及びそのコンジュゲート並びにそれらの使用 | |
| HK40117209A (zh) | 一种靶向ror1的结合分子及其应用 |